Innovation in Drug Delivery Devices by Novo Nordisk Over the years, Novo Nordisk has reshaped how injectable medications are delivered, making them safer, more accurate, and patient-friendly
Eligible patients in Maryland and Delaware may receive in-person or telehealth care based on their location and clinical needs Some patients notice changes in appetite during the first few doses, while others require gradual dose escalation before experiencing a meaningful effect
Retatrutide and other investigational compounds are not approved by the U.S
I work with patients to develop transition plans that may include: Slowly tapering the medication instead of stopping it suddenly Tightening up nutrition, protein intake, and strength training before coming off Discussing whether a lower maintenance dose makes sense for some women Addressing the hormone shifts and metabolic factors that were contributing in the first place Rare Risks, Contraindications, and When GLP-1 Medications Are Not Appropriate While GLP-1 medications are generally well-tolerated and highly effective for many patients, they are not appropriate for everyone